This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy Manufacturing & Commercialization US
September 23-26, 2024
Hynes Convention CenterBoston, MA

Kenneth Green, PhD
Snr Dir MSAT at Vertex


Currently responsible for MSAT at Vertex for Cell & Gene Therapy within Commercial Manufacturing and Supply Chain. Previously held leadership roles managing DS Operations and MSAT functions at Samsung Biologics, S Korea. Ken has prior experience in process development & characterization, technology transfer, validation and production including leadership roles in Process Development and Technical Services with Lonza, GSK, Amgen, Pfizer and Shire. Ken has a passion for continuous improvement with application of six and lean sigma methodologies for efficiency gains, problem solving and strategy deployment. Graduated with degree in Microbiology from University of Sheffield, UK, followed by MSc and PhD degrees in Biochemical Engineering from University of Birmingham, UK.

Agenda Sessions

  • Building the capabilities for success in Cell Therapy Commercialization